FDA Approves New Drug For DMD Patients Despite Its Ineffectiveness

Ring of Fire's Mike Papantonio and Sam Seder discuss how the new drug designed for Duchenne muscular dystrophy patients, has been pushed onto the market by the FDA, despite the fact that their own scientists question the effectiveness of the new blockbuster drug from Sarepta Therapeutics. SUBSCRIBE to Ring Of Fire: https://www.youtube.com/user/golefttv Subscribe to the ROF Podcast for more great content: http://www.ROFPodcast.com